Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan L Wright

Showing results (171-180 of 204) with videos related to

Pageof 21
Sort By:
Genome Medicine|October 18, 2019
Long non-coding RNAs identify a subset of luminal muscle-invasive bladder cancer patients with favorable prognosisJoep J de Jong, Yang Liu, A Gordon Robertson, et al.
Clinical Genitourinary Cancer|September 12, 2024
Small Cell Bladder Cancer: Treatment Patterns for Local Disease and Associated Outcomes. A Retrospective Cohort StudyDimitra Rafailia Bakaloudi, Elizabeth L Koehne, Leonidas N Diamantopoulos, et al.
Clinical Genitourinary Cancer|November 8, 2020
Response to Neoadjuvant Chemotherapy and Survival in Micropapillary Urothelial Carcinoma: Data From a Tertiary Referral Center and the Surveillance, Epidemiology, and End Results (SEER) ProgramLeonidas N Diamantopoulos, Sarah K Holt, Ali R Khaki, et al.
Cancer Cell|April 21, 2023
Transcriptional-translational conflict is a barrier to cellular transformation and cancer progressionSujata Jana, Sandipan Brahma, Sonali Arora, et al.
BJU International|September 27, 2020
Comparative effectiveness of neoadjuvant chemotherapy in bladder and upper urinary tract urothelial carcinomaDavid D'Andrea, Surena Matin, Peter C Black, et al.
Urologic Oncology|May 2, 2025
Prospective evaluation of comprehensive geriatric assessments in multidisciplinary bladder cancer care and implications for personalized vulnerability phenotypingDana Cavanaugh, Sarah K Holt, Erin Dwyer, et al.
Urologic Oncology|February 8, 2021
Patterns and timing of perioperative blood transfusion and association with outcomes after radical cystectomyLeonidas N Diamantopoulos, Rishi R Sekar, Sarah K Holt, et al.
Clinical Genitourinary Cancer|May 7, 2023
Sarcomatoid Urothelial Carcinoma Is Associated With Limited Response to Neoadjuvant Chemotherapy and Poor Oncologic Outcomes After Radical CystectomyRishi R Sekar, Leonidas N Diamantopoulos, Dimitra R Bakaloudi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2018
Divergent Biological Response to Neoadjuvant Chemotherapy in Muscle-invasive Bladder CancerRoland Seiler, Ewan A Gibb, Natalie Q Wang, et al.
European Urology|August 5, 2025
Neoadjuvant Pembrolizumab and Accelerated Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Nonurothelial Histologic Subtypes of Muscle-invasive Bladder Cancer: A Phase 2 TrialRuben Raychaudhuri, Ali Raza Khaki, Mary W Redman, et al.
Pageof 21

Showing results (171-180 of 204) with videos related to

Sort By:
Pageof 21
Genome Medicine|October 18, 2019
Long non-coding RNAs identify a subset of luminal muscle-invasive bladder cancer patients with favorable prognosisJoep J de Jong, Yang Liu, A Gordon Robertson, et al.
Clinical Genitourinary Cancer|September 12, 2024
Small Cell Bladder Cancer: Treatment Patterns for Local Disease and Associated Outcomes. A Retrospective Cohort StudyDimitra Rafailia Bakaloudi, Elizabeth L Koehne, Leonidas N Diamantopoulos, et al.
Clinical Genitourinary Cancer|November 8, 2020
Response to Neoadjuvant Chemotherapy and Survival in Micropapillary Urothelial Carcinoma: Data From a Tertiary Referral Center and the Surveillance, Epidemiology, and End Results (SEER) ProgramLeonidas N Diamantopoulos, Sarah K Holt, Ali R Khaki, et al.
Cancer Cell|April 21, 2023
Transcriptional-translational conflict is a barrier to cellular transformation and cancer progressionSujata Jana, Sandipan Brahma, Sonali Arora, et al.
BJU International|September 27, 2020
Comparative effectiveness of neoadjuvant chemotherapy in bladder and upper urinary tract urothelial carcinomaDavid D'Andrea, Surena Matin, Peter C Black, et al.
Urologic Oncology|May 2, 2025
Prospective evaluation of comprehensive geriatric assessments in multidisciplinary bladder cancer care and implications for personalized vulnerability phenotypingDana Cavanaugh, Sarah K Holt, Erin Dwyer, et al.
Urologic Oncology|February 8, 2021
Patterns and timing of perioperative blood transfusion and association with outcomes after radical cystectomyLeonidas N Diamantopoulos, Rishi R Sekar, Sarah K Holt, et al.
Clinical Genitourinary Cancer|May 7, 2023
Sarcomatoid Urothelial Carcinoma Is Associated With Limited Response to Neoadjuvant Chemotherapy and Poor Oncologic Outcomes After Radical CystectomyRishi R Sekar, Leonidas N Diamantopoulos, Dimitra R Bakaloudi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2018
Divergent Biological Response to Neoadjuvant Chemotherapy in Muscle-invasive Bladder CancerRoland Seiler, Ewan A Gibb, Natalie Q Wang, et al.
European Urology|August 5, 2025
Neoadjuvant Pembrolizumab and Accelerated Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Nonurothelial Histologic Subtypes of Muscle-invasive Bladder Cancer: A Phase 2 TrialRuben Raychaudhuri, Ali Raza Khaki, Mary W Redman, et al.
Pageof 21